Author

Pilar Frontelo

Observed name: P. Frontelo

Institution: PharmaMar (Spain)

Observed institutions: Institut Català d'Oncologia, PharmaMar (Spain), University of Glasgow

OpenAlex ID: A5111968401

A retrospective pooled analysis of trabectedin safety in 1,132 patients with solid tumors treated in phase II clinical trials

2011 · Axel Le Cesne, Alejandro Yovine, et al. · Investigational New Drugs · 78

Phase I dose-escalating study of PM02734 in a 24-hour infusion schedule every 21 days in advanced solid tumors

2009 · T. R. Evans, A. Oaknin, et al. · Journal of Clinical Oncology · 1

Works count: 2

Citation count: 79

H-index: 1

I10-index: 1